Sungho Ahn

Title: Sungho Ahn: Innovator in Antibody Development

Introduction

Sungho Ahn is a prominent inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 2 patents, Ahn's work focuses on innovative solutions for treating autoimmune diseases and cancer.

Latest Patents

Ahn's latest patents include the "Anti-VISTA antibody and use thereof" and the "Anti-PD-L1 antibody and use thereof." The first patent relates to an anti-VISTA antibody or an antigen-binding fragment, along with a method for preparing the antibody. This invention also includes a composition for the prevention or treatment of autoimmune diseases. The second patent discloses an anti-PD-L1 antibody, which is crucial for developing pharmaceutical compositions aimed at preventing or treating cancer. Both patents highlight Ahn's commitment to advancing medical science through innovative antibody therapies.

Career Highlights

Sungho Ahn is currently associated with Pharmabcine Inc., where he continues to push the boundaries of antibody research. His work has garnered attention in the scientific community, contributing to the development of novel therapeutic strategies.

Collaborations

Ahn collaborates with notable colleagues, including Sang Soon Byun and Keunhee Oh, who share his vision for advancing biotechnology. Their combined expertise enhances the potential for groundbreaking discoveries in the field.

Conclusion

Sungho Ahn's contributions to antibody development are paving the way for new treatments in autoimmune diseases and cancer. His innovative patents reflect a dedication to improving healthcare through scientific advancements.